| SAREPTA THERAPEUTICS |
| USA |
| Gesundheit |
| US8036071004 / A1J1BH |
| AB3A (Frankfurt) / SRPT (NASDAQ) |
| FRA:AB3A, ETR:AB3A, AB3A:GR, NASDAQ:SRPT |
| - |
| https://www.sarepta.com/ |
|
Sarepta Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of precision genetic medicines for rare diseases. It specializes ..
>Volltext.. |
| 1602.1 Mio. EUR |
| 1687.21 Mio. EUR |
| 1894.08 Mio. EUR |
| -512.18 Mio. EUR |
| -726.18 Mio. EUR |
| -7.17 EUR |
| 895.71 Mio. EUR |
| 690.41 Mio. EUR |
| -191.75 Mio. EUR |
| 0.86 |
| 1.87% |
| -415.78% |
| - |
| - |
| - |
| SAREPTA, AVI BIOPHARMA |
| 25.03.26 |
|
||||
|
||||
|
||||
|